Fazekas-Lavu M, Tonks K, Samaras K
Front Endocrinol (Lausanne). 2018; 9:634.
PMID: 30429826
PMC: 6220317.
DOI: 10.3389/fendo.2018.00634.
Gundurao Sreekantamurthy G, Singh N, Singh T, Singh T, Singh K
J Nutr Metab. 2014; 2014:498497.
PMID: 25013726
PMC: 4070330.
DOI: 10.1155/2014/498497.
Lipshultz S, Miller T, Wilkinson J, Scott G, Somarriba G, Cochran T
J Int AIDS Soc. 2013; 16:18597.
PMID: 23782480
PMC: 3687072.
DOI: 10.7448/IAS.16.1.18597.
Pirrone V, Libon D, Sell C, Lerner C, Nonnemacher M, Wigdahl B
Future Virol. 2013; 8(1):81-101.
PMID: 23596462
PMC: 3625689.
DOI: 10.2217/fvl.12.127.
Eckard A, Tangpricha V, Seydafkan S, ORiordan M, Storer N, Labbato D
Pediatr Infect Dis J. 2013; 32(11):1224-9.
PMID: 23360833
PMC: 3750101.
DOI: 10.1097/INF.0b013e318286c793.
[HIV infection : chronic disease with comorbidities].
Bogner J
Internist (Berl). 2012; 53(10):1169-78.
PMID: 22986542
DOI: 10.1007/s00108-011-2972-7.
Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.
Gutierrez A, Balasubramanyam A
Endocrine. 2011; 41(1):1-10.
PMID: 22134974
PMC: 3417129.
DOI: 10.1007/s12020-011-9565-z.
Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients.
Freitas P, Carvalho D, Souto S, Santos A, Xerinda S, Marques R
BMC Infect Dis. 2011; 11:246.
PMID: 21933422
PMC: 3187742.
DOI: 10.1186/1471-2334-11-246.
Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s.
McComsey G, Kitch D, Sax P, Tebas P, Tierney C, Jahed N
Clin Infect Dis. 2011; 53(2):185-96.
PMID: 21690627
PMC: 3165963.
DOI: 10.1093/cid/cir324.
Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.
Miller T, Somarriba G, Orav E, Mendez A, Neri D, Schaefer N
J Acquir Immune Defic Syndr. 2010; 55(2):182-8.
PMID: 20531209
PMC: 2943965.
DOI: 10.1097/QAI.0b013e3181e222c9.
Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.
Kim R, Rutstein R
Paediatr Drugs. 2010; 12(3):187-99.
PMID: 20481647
DOI: 10.2165/11532520-000000000-00000.
Gender-specific effects of HIV protease inhibitors on body mass in mice.
Wilson M, Allred K, Kordik E, Jasper D, Rosewell A, Bisotti A
AIDS Res Ther. 2007; 4:8.
PMID: 17472747
PMC: 1868754.
DOI: 10.1186/1742-6405-4-8.
Site-specific reduction of oxidative and lipid metabolism in adipose tissue of 3'-azido-3'-deoxythymidine-treated rats.
Deveaud C, Beauvoit B, Reynaud A, Bonnet J
Antimicrob Agents Chemother. 2006; 51(2):583-90.
PMID: 17158934
PMC: 1797728.
DOI: 10.1128/AAC.01078-06.
Abnormalities in the bone mineral metabolism in HIV-infected patients.
Garcia Aparicio A, Munoz Fernandez S, Gonzalez J, Arribas J, Pena J, Vazquez J
Clin Rheumatol. 2005; 25(4):537-9.
PMID: 16208429
DOI: 10.1007/s10067-005-0028-x.
Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children.
Sanchez Torres A, Munoz Muniz R, Madero R, Borque C, Garcia-Miguel M, Gomez M
Eur J Pediatr. 2005; 164(5):271-6.
PMID: 15650834
DOI: 10.1007/s00431-004-1610-y.
Early versus delayed antiretroviral therapy in patients with HIV infection : a review of the current guidelines from an immunological perspective.
Thorner A, Rosenberg E
Drugs. 2003; 63(13):1325-37.
PMID: 12825959
DOI: 10.2165/00003495-200363130-00001.
